Breast imaging can predict cancer recurrence

Sarah Anwar, MDLinx

San Antonio Breast Cancer Symposium 2017

San Antonio, Texas, United States | December 05-09, 2017

At the 2018 Best of SABCS-NY, Sheldon Feldman, MD, FACS, chief of breast surgery and breast surgical oncology, Montefiore-Einstein Cancer Center, New York, director of breast cancer services and professor of surgery at Montefiore Medical Center, Albert Einstein College of Medicine, shared interesting finding from a study by Chitalia, et al, University of Pennsylvania, originally presented at the 2017 Symposium.

In this study, researchers were able to use dynamic breast MRI texture analysis to determine the heterogeneity of tumor cells. “What’s very interesting in this trial is that MRI features of marked heterogeneity really predicted patients who were at the highest risk for recurrence,” said Dr. Feldman

“In fact,” he continued, “all of the 14 patients in this study who developed recurrence were all of this heterogenous population, which was predicted by this MRI.”

All Interviews

From this Conference

3:14

Managing patients with high risk breast lesions
Amy C. Degnim, MD, professor of surgery, Mayo Clinic, Rochester, MN, discusses the different management strategies for lesions that put patients at increased risk for breast...
Amy C. Degnim, MD
1:15

The paradoxical role of family history in breast cancer risk
Although family history can influence a patient’s risk of developing breast cancer, it does not increase that risk once other risk factors are identified.
Amy C. Degnim, MD
7:15

Seamless designs for clinical trials: A new wave in drug development, explained
With the movement toward developing more targeted therapies, the FDA has updated its drug development system to include what they have designated as ‘seamless...
Tatiana Prowell, MD

0:52

Value of chemotherapy for patients with locoregional breast cancer recurrence
In patients with locoregional recurrence of breast cancer, the effects of chemotherapy are varied, depending on whether they have hormone receptor positive or hormone receptor...
William Gradishar, MD
4:23

Circulating tumor cells as prognostic biomarkers for recurrence of breast cancer
At the 2018 Best of San Antonio Breast Cancer Symposium-New York, Joseph Sparano, MD, professor of medicine and women’s health, Albert Einstein College of Medicine,...
Joseph A. Sparano, MD
2:51

Multidisciplinary management of locoregional breast cancer recurrence
Locoregional recurrences of breast cancers are rare, but when they do occur, can be challenging and typically require a multidisciplinary evaluation.
William Gradishar, MD

This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium 2017.